Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma

Detalles Bibliográficos
Autores principales: Lin, Quande, Liu, Xiyang, Han, Lu, Liu, Lina, Fang, Baijun, Gao, Quanli, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269899/
https://www.ncbi.nlm.nih.gov/pubmed/31537902
http://dx.doi.org/10.1038/s41409-019-0674-2
_version_ 1783541821303947264
author Lin, Quande
Liu, Xiyang
Han, Lu
Liu, Lina
Fang, Baijun
Gao, Quanli
Song, Yongping
author_facet Lin, Quande
Liu, Xiyang
Han, Lu
Liu, Lina
Fang, Baijun
Gao, Quanli
Song, Yongping
author_sort Lin, Quande
collection PubMed
description
format Online
Article
Text
id pubmed-7269899
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72698992020-06-15 Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma Lin, Quande Liu, Xiyang Han, Lu Liu, Lina Fang, Baijun Gao, Quanli Song, Yongping Bone Marrow Transplant Correspondence Nature Publishing Group UK 2019-09-19 2020 /pmc/articles/PMC7269899/ /pubmed/31537902 http://dx.doi.org/10.1038/s41409-019-0674-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Lin, Quande
Liu, Xiyang
Han, Lu
Liu, Lina
Fang, Baijun
Gao, Quanli
Song, Yongping
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
title Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
title_full Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
title_fullStr Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
title_full_unstemmed Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
title_short Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
title_sort autologous hematopoietic stem cell infusion for sustained myelosuppression after bcma–car-t therapy in patient with relapsed myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269899/
https://www.ncbi.nlm.nih.gov/pubmed/31537902
http://dx.doi.org/10.1038/s41409-019-0674-2
work_keys_str_mv AT linquande autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma
AT liuxiyang autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma
AT hanlu autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma
AT liulina autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma
AT fangbaijun autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma
AT gaoquanli autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma
AT songyongping autologoushematopoieticstemcellinfusionforsustainedmyelosuppressionafterbcmacarttherapyinpatientwithrelapsedmyeloma

Ejemplares similares